Daiichi Sankyo at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Daiichi Sankyo brings 5 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work spans PEGylated liposomes, linking their design to where they travel in the body, and high-concentration antibody products. Projects also predict antibody aggregation and viscosity with simulation and machine learning, and speed reconstitution of freeze-dried biologics.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Daiichi Sankyo Tokyo, Japan | |
Japanese pharmaceutical company with oncology medicines, including antibody-drug conjugates, and cardiovascular drugs. | Poster Mon Oct 26 10:30am–11:30am Influence of pH, Alcohol Structure, and Temperature on Lenalidomide Alcoholysis with Implications for Pharmaceutical Quality Control Poster Mon Oct 26 10:30am–11:30am Linking PEGylation Design to Liposomal Biodistribution through Combined IVIS Imaging and ¹H NMR Analysis Poster Mon Oct 26 3:30pm–4:30pm Feasibility Study on Predicting Antibody Aggregation and Viscosity Using Molecular Dynamics Simulation and Machine Learning Poster Tue Oct 27 1:30pm–2:30pm Physicochemical Characterization of PEGylated Liposomes by 1 H NMR: Relationship between PEG Molecular State and In Vivo Pharmacokinetics Poster Wed Oct 28 10:30am–11:30am Moderate-Temperature Long-Duration Annealing Enables Rapid Reconstitution of High-Concentration Lyophilized Biopharmaceuticals |
Instantly find 20 buyers from Daiichi Sankyo
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction